SEBI Reg. Investment Advisor

Download App

Help Center Pricing

Recent:

Top Pharma Companies in India by Market Cap

BSE Sensex 77973.06
14.54 (0.02%)

Filter

Top Pharma Companies in India as on May-2026 | 5 Star Rated Stocks Undervalued Stocks Fair Valued Stocks Uptrend Stocks

Filter

	Company Name	DeciZen	Market cap (Rs. Cr.)	CMP (Change %)	Latest P/E	Latest P/BV	5Y Sales Gr.(%)	5Y Profit Gr.(%)
1	Sun Pharmaceutical Industries Ltd.	Q V+ PT	4,43,973 Large Cap	1,836.70 (-0.74%)	40.67	5.47	9.87	23.50	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
2	Divis Laboratories Ltd.	Q V+ PT	1,78,026 Large Cap	6,722.45 (0.24%)	71.81	11.13	11.65	10.50	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
3	Torrent Pharmaceuticals Ltd.	Q V+ PT	1,47,478 Large Cap	4,382.55 (0.57%)	64.91	16.23	7.72	15.29	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
4	Lupin Ltd.	Q V+ PT	1,11,668 Mid Cap	2,464 (0.89%)	24.04	5.37	8.11	0.00	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
5	Apollo Hospitals Enterprise Ltd.	Q V+ PT	1,11,527 Large Cap	7,816.60 (0.77%)	77.25	11.5	-3.49	29.94	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
6	Cipla Ltd.	Q V PT	1,10,283 Large Cap	1,371.70 (0.47%)	24.26	3.28	9.97	30.14	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
7	Dr. Reddys Laboratories Ltd.	Q V PT	1,09,382 Mid Cap	1,306.75 (-0.29%)	19.64	2.94	13.26	22.29	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
8	Max Healthcare Institute Ltd.	Q V PT	98,852 Mid Cap	1,013.65 (-0.20%)	69.65	9.54	46.01	60.18	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
9	Mankind Pharma Ltd.	Q V PT	97,506 Mid Cap	2,355.75 (-0.26%)	57.24	6.11	14.65	12.79	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
10	Zydus Lifesciences Ltd.	Q V PT	94,495 Mid Cap	939.65 (0.06%)	19.13	3.6	10.27	30.57	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
11	Aurobindo Pharma Ltd.	Q V+ PT	86,156 Mid Cap	1,480.50 (-0.20%)	40.43	3.91	-3.95	-0.50	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
12	Fortis Healthcare Ltd.	Q V+ PT	72,283 Mid Cap	950.25 (-0.75%)	443.08	7.85	15.55	-22.45	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
13	Glenmark Pharmaceuticals Ltd.	Q V+ PT	66,987 Mid Cap	2,372.80 (-0.04%)	62.89	6.71	4.60	14.41	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
14	Alkem Laboratories Ltd.	Q V+ PT	66,240 Mid Cap	5,606.65 (1.20%)	30.19	4.64	5.71	10.33	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
15	Laurus Labs Ltd.	Q V+ PT	63,517 Mid Cap	1,205.20 (2.44%)	71.46	11.98	14.42	4.11	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
16	Biocon Ltd.	Q V PT	61,716 Mid Cap	384.55 (1.00%)	8340.01	2.29	2.44	-9.71	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
17	Abbott India Ltd.	Q V PT	55,876 Mid Cap	26,670 (1.42%)	36.66	12.74	9.38	18.78	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
18	Anthem Biosciences Ltd.	Q V PT	43,162 Mid Cap	772.45 (0.53%)	85.27	14.55	23.81	40.64	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
19	Glaxosmithkline Pharmaceuticals Ltd.	Q V+ PT	41,069 Mid Cap	2,484.80 (2.50%)	40.22	20.5	3.06	33.10	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
20	Ipca Laboratories Ltd.	Q V+ PT	39,672 Mid Cap	1,565.85 (0.14%)	49.27	5.14	8.87	4.68	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
21	Ajanta Pharma Ltd.	Q V PT	38,646 Small Cap	3,103.30 (0.32%)	36.6	8.54	12.43	17.07	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
22	Aster DM Healthcare Ltd.	Q V+ PT	37,880 Small Cap	740.05 (1.22%)	97.59	8.28	-13.71	0.61	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
23	Narayana Hrudayalaya Ltd.	Q V+ PT	37,598 Mid Cap	1,861.70 (1.19%)	48.27	8.97	11.88	45.85	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
24	JB Chemicals & Pharmaceuticals Ltd.	Q V+ PT	34,370 Small Cap	2,144.30 (0.17%)	47.25	8.81	17.81	19.45	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
25	Global Health Ltd.	Q V PT	31,764 Small Cap	1,206.80 (2.15%)	68.24	8.18	16.83	34.86	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
26	Emcure Pharmaceuticals Ltd.	Q V PT	31,472 Small Cap	1,657.25 (-0.17%)	42.94	8.48	13.02	9.98	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
27	Gland Pharma Ltd.	Q V PT	29,863 Small Cap	1,875.20 (3.46%)	25.54	2.88	9.35	7.37	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
28	Krishna Institute of Medical Sciences Ltd	Q V PT	28,050 Small Cap	703.55 (0.36%)	97.29	11.87	11.87	17.04	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
29	Wockhardt Ltd.	Q V+ PT	27,953 Small Cap	1,640 (-4.67%)	131.23	5.66	1.15	0.00	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
30	Dr. Lal Pathlabs Ltd.	Q V PT	26,598 Small Cap	1,606.90 (1.28%)	52.34	10.76	13.05	17.98	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History

Screens:

AlphaCases Top Rated Stocks Best Nifty Stocks Best Nifty Next Stocks Best Nifty 500 Stocks Best SmallCap Stocks Top BFSI Stocks

Pharma - Today's Top Gainers

Company Name	CMP	Price Change(%)
Indoco Remedies	259.50	13.84%
Piramal Pharma	184.85	11.96%
Nectar Lifesciences	13.21	6.88%
Guj. Kidney & Super	131.40	6.44%
Sun Pharma Adv. Res	165.45	5.35%

Pharma - Today's Top Losers

Company Name	CMP	Price Change(%)
Wockhardt	1,640	-4.67%
Rubicon Research	962.60	-3.65%
Concord Biotech	1,198.70	-1.99%
Dr. Agarwals Health	449.25	-1.94%
Kwality Pharma	1,694	-1.85%

News about Top Pharma Companies in India

May, 2026

USFDA concludes GMP surveillance inspection at Zydus Lifesciences’ Ahmedabad facility

The inspection closed with seven observations

May, 2026

Zydus Lifesciences informs about press release

Zydus Lifesciences has enclosed a copy of press release dated May 6, 2026, titled ‘USFDA inspection concludes at Zydus' Biologics Injectable plant, Ahmedabad’. The contents of the press release give full details.

The above information is a part of company’s filings submitted to BSE.

May, 2026

Aurobindo Pharma zooms after getting EIR for Telangana unit

The USFDA has classified the said facility as Voluntary Action Indicated

May, 2026

Aurobindo Pharma gets EIR for Telangana unit

The USFDA has classified the said facility as Voluntary Action Indicated

May, 2026

Aurobindo Pharma informs about updates

Pursuant to Regulation 30 of the SEBI (Listing Obligations & Disclosure Requirements) Regulations, 2015, Aurobindo Pharma has informed that the United States Food and Drug Administration (US FDA) inspected Aurobindo Pharma’s Unit-VII, an oral solid dosage manufacturing unit, situated at Special Economic Zone (Pharma), TSIIC, Green Industrial Park, Polepally Village, Jedcherla Mandal, Mahaboobnagar District, 509302, Telangana from January 28 to February 10, 2026. At the end of the inspection, a ‘Form 483’ was issued with a total of 9 observations. The Unit has now received Establishment Inspection Report (EIR) classifying the facility as ‘Voluntary Action Indicated’ (‘VAI’). FDA has concluded that this inspection is now closed.

The above information is a part of company’s filings submitted to BSE.

May, 2026

Ajanta Pharma - Quaterly Results

The Revenue for the quarter ended March 2026 of Rs. 12105.30 millions grew by 19.39 % from Rs. 10139.40 millions.Net profit showed a marginal rise at Rs. 1972.80 millions for the quarter ended March 2026, as compared to corresponding quarter of last year.Operating profit surged to 3010.30 millions from the corresponding previous quarter of 2675.80 millions.

(Rs. in Million)

	Quarter ended			Year to Date			Year ended
	202603	202503	% Var	202603	202503	% Var	202603	202503	% Var
Sales	12105.30	10139.40	19.39	48459.20	43220.40	12.12	48459.20	43220.40	12.12
Other Income	629.80	179.30	251.25	2044.00	1198.70	70.52	2044.00	1198.70	70.52
PBIDT	3010.30	2675.80	12.50	14023.90	13245.90	5.87	14023.90	13245.90	5.87
Interest	-7.40	6.70	-210.45	25.90	46.00	-43.70	25.90	46.00	-43.70
PBDT	3017.70	2669.10	13.06	13998.00	13199.90	6.05	13998.00	13199.90	6.05
Depreciation	441.60	387.60	13.93	1687.70	1399.30	20.61	1687.70	1399.30	20.61
PBT	2576.10	2281.50	12.91	12310.30	11800.60	4.32	12310.30	11800.60	4.32
TAX	603.30	347.20	73.76	2842.10	2631.70	7.99	2842.10	2631.70	7.99
Deferred Tax	-70.00	-43.80	59.82	76.00	51.40	47.86	76.00	51.40	47.86
PAT	1972.80	1934.30	1.99	9468.20	9168.90	3.26	9468.20	9168.90	3.26
Equity	250.70	250.70	0.00	250.70	250.70	0.00	250.70	250.70	0.00
PBIDTM(%)	24.87	26.39	-5.77	28.94	30.65	-5.57	28.94	30.65	-5.57

Top 10 Publicly Listed pharmaceutical stocks in India by Market Capitalization as of 2026.

Rank	Company	Market Capitalization 2026 (INR crores)
1	Sun Pharmaceutical Industries Ltd.	4,43,973 Crore
2	Divis Laboratories Ltd.	1,78,026 Crore
3	Torrent Pharmaceuticals Ltd.	1,47,478 Crore
4	Lupin Ltd.	1,11,668 Crore
5	Apollo Hospitals Enterprise Ltd.	1,11,527 Crore
6	Cipla Ltd.	1,10,283 Crore
7	Dr. Reddys Laboratories Ltd.	1,09,382 Crore
8	Max Healthcare Institute Ltd.	98,852 Crore
9	Mankind Pharma Ltd.	97,506 Crore
10	Zydus Lifesciences Ltd.	94,495 Crore

Do you know? Asking 3 Right Questions minimizes the RISK of Stock Investing To Know

Right Stock | Right Price | Right Allocation

Find best stocks to buy now Find best pharma stocks to buy now

Top 15 Pharma Stocks by Revenue Growth

Top Pharma Companies Source: NSE Indices

You can use different criterias to arrive at the list of best stocks in the Nifty Pharma company index. You can use return ratios like ROCE or ROE, that will help you choose companies with profitable growth.

Based on ROE, the best stocks in the Nifty Pharma companies index are:

Company Name	Is it a Right Stock ?	CMP	Market Cap(Cr.)	P/E	P/BV	EV/EBITDA	ROE
Abbott India Ltd. (M)	Very Good	26,670	55,876	36.66	12.74	25.65	35.71
Torrent Pharmaceuticals Ltd. (L)	Very Good	4,383	1,47,478	64.91	16.23	36.68	26.68
Ajanta Pharma Ltd. (S)	Very Good	3,103	38,646	36.60	8.54	24.73	24.45
Lupin Ltd. (M)	Somewhat Good	2,464	1,11,668	24.04	5.37	14.31	20.83
Zydus Lifesciences Ltd. (M)	Very Good	940	94,495	19.13	3.60	11.92	20.74

Based on the past year's gain, the best performing stocks are:

Company Name	Is it a Right Stock ?	CMP	Market Cap(Cr.)	Yearly gain (%)
Laurus Labs Ltd. (M)	Very Good	1,205	63,517	92.14
Glenmark Pharmaceuticals Ltd. (M)	Very Good	2,373	66,987	68.93
JB Chemicals & Pharmaceuticals Ltd. (S)	Very Good	2,144	34,370	42.38
Wockhardt Ltd. (S)	Not Good	1,640	27,953	39.71
Torrent Pharmaceuticals Ltd. (L)	Very Good	4,383	1,47,478	33.30
				View More

Stocks with the highest revenue growth in the past 5 years is:

Company Name	Is it a Right Stock ?	CMP	Market Cap(Cr.)	P/E	P/BV	EV/EBITDA	5Y Sales Growth (%)
JB Chemicals & Pharmaceuticals Ltd. (S)	Very Good	2,144	34,370	47.25	8.81	29.84	17.81
Mankind Pharma Ltd. (M)	Very Good	2,356	97,506	57.24	6.11	34.36	14.65
Laurus Labs Ltd. (M)	Very Good	1,205	63,517	71.46	11.98	35.90	14.42
Dr. Reddys Laboratories Ltd. (M)	Very Good	1,307	1,09,382	19.64	2.94	11.80	13.26
Ajanta Pharma Ltd. (S)	Very Good	3,103	38,646	36.60	8.54	24.73	12.43

Stocks with high profit growth often witness their stock prices gaining, irrespective of the market movements.

Stocks with the highest profit growth in the past 5 years is:

Company Name	Is it a Right Stock ?	CMP	Market Cap(Cr.)	P/E	P/BV	EV/EBITDA	5Y Profit Growth (%)
Zydus Lifesciences Ltd. (M)	Very Good	940	94,495	19.13	3.60	11.92	30.57
Cipla Ltd. (L)	Very Good	1,372	1,10,283	24.26	3.28	14.63	30.14
Sun Pharmaceutical Industries Ltd. (L)	Very Good	1,837	4,43,973	40.67	5.47	22.24	23.50
Dr. Reddys Laboratories Ltd. (M)	Very Good	1,307	1,09,382	19.64	2.94	11.80	22.29
JB Chemicals & Pharmaceuticals Ltd. (S)	Very Good	2,144	34,370	47.25	8.81	29.84	19.45

You’ve reached your free data limit. Unlock unlimited data views for free. Login | Register Now

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Fiduciary-first advisory model.
As SEBI-registered IAs, we are legally and ethically bound to act in the best interests of our clients. We do not sell or distribute any financial products. This ensures our guidance is 100% unbiased and conflict-free.
Deep fundamental research + robust valuation discipline.
Built on more than 15 years of equity research, our framework combines quality assessment, intrinsic value estimation, and a sensible margin-of-safety approach.
Process—not predictions.
We don’t rely on guesswork or market timing. Instead, we focus on asset allocation, risk management, and long-term compounding.
Technology + Human Intelligence.
We believe a combination of both is essential for investing success. We constantly innovate and upgrade in-house tools, financial X-rays, and portfolio analytics so that our team of analysts and advisors are equipped with the best.
Partner with Clients.
We follow a DIWM (Do-It-With-Me) approach where we partner clients in setting goals, financial planning, educating on our investing process and share decision-enabling resources transparently with our clients who retain control on execution.

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

Investing in stocks, mutual funds, debt, and gold
Quality-at-Reasonable-Price way of investing in stocks
Constructing Direct Stock Portfolios with Core, Booster, and Amplifier stocks
A Mutual Fund Portfolio that delivers consistent out-performance and meaningful diversification (low overlap)
Periodic review and rebalancing
Clear Buy-Sell-Hold, and Position-sizing frameworks

Name of the IA registered with SEBI:	The Alchemists Ark Pvt. Ltd.
Logo:
Trade/Brand Name of IA:	MoneyWorks4Me Investment Advisers
Brand Logo:
SEBI Registration Number:	INA000013323 Validity – May 16, 2019 – Perpetual
Registration:	Non-Individual
BSE Enlistment No:	1187
Address:	B-101, Signet Corner Building, Balewadi Phata, Baner, Pune, Maharashtra 411045
Compliance officer Details:	Name: Shrikant Jagtap Email: shrikant.jagtap@moneyworks4me.com Telephone: +919860359463 Address: Same as IA
Grievance Officer Details:	Name: Mukta Vaze Email: mukta.vaze@moneyworks4me.com Telephone: +91 98609 19463 Address: Same as IA
Principal Officer Details:	Name: Atharva Bhide Email: atharva.bhide@moneyworks4me.com Telephone: +91 91758 99463 Address: Same as IA
Standard Warning:	Investment in securities market are subject to market risks. Read all the related documents carefully before investing.
Disclaimer:	Registration granted by SEBI, enlistment with exchange and certification from NISM in no way guarantee performance of the intermediary or provide any assurance of returns to investors.

Top Pharma Companies in India by Market Cap

News about Top Pharma Companies in India

USFDA concludes GMP surveillance inspection at Zydus Lifesciences’ Ahmedabad facility

Zydus Lifesciences informs about press release

Aurobindo Pharma zooms after getting EIR for Telangana unit

Aurobindo Pharma gets EIR for Telangana unit

Aurobindo Pharma informs about updates

Ajanta Pharma - Quaterly Results

Publicly traded pharmaceuticals

Top 10 Publicly Listed pharmaceutical stocks in India by Market Capitalization as of 2026.

Top 15 Pharma Stocks by Revenue Growth

Top Pharma Companies Source: NSE Indices

How to select the top Nifty Pharma stocks based on RoE?

What are the best-performing stocks in the Nifty Pharma index?

Which Nifty Pharma stocks have the highest revenue growth in the past five years?

Which Nifty Pharma stocks had the highest profit growth in the past five years ?

About MoneyWorks4Me

Our Vision

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.